2269.HK 财务： WuXi Biologics (Cayman) Inc. AI 分析

Q: 技术分析指标如何适用于 2269.HK？

根据技术分析，WuXi Biologics (Cayman) Inc. 的综合信号为 Strong Buy。WuXi Biologics (Cayman) Inc. 有 5 个买入信号，2 个中性信号和 0 个卖出信号。

Q: 2269.HK 的斐波那契回调水平是多少？

WuXi Biologics (Cayman) Inc. 的斐波那契回调水平是 在 78.6% 和 100% 之间。

Q: WuXi Biologics (Cayman) Inc. 的 RSI 是多少？

WuXi Biologics (Cayman) Inc. 的 RSI 目前为 50.58，表明处于 中立 状态

Q: WuXi Biologics (Cayman) Inc. 接下来 12 个月的价格是多少？

WuXi Biologics (Cayman) Inc. 2269.HK 接下来 12 个月的价格预计为 $40.88。

Q: WuXi Biologics (Cayman) Inc. 预计会涨到多高？

据华尔街分析师称，WuXi Biologics (Cayman) Inc. 预计将达到 $54.6 的高预测值。

主页

股票

2269.HK

预测

WUXI BIO (2269.HK)

WuXi Biologics (Cayman) Inc.

HK$38.06

2.86%

$1.06

休市： Jan 21, 16:00:00 HKT

关键数据

前收盘价

$37.1

开盘价

$37

当日区间

$36.84 - $38.46

52周范围

$16.2 - $42.6

交易量

17.0M

平均成交量

33.9M

每股收益（TTM）

1.09

股息收益率

市值

$157.1B

什么是 WUXI BIO？

Wuxi Biologics (Cayman), Inc. is an investment holding company, which provides end-to-end solutions and services for biologics discovery, development, and manufacturing services and manufacturing of biologics products. The company is headquartered in Wuxi, Jiangsu and currently employs 12,552 full-time employees. The company went IPO on 2017-06-13. The firm mainly operates its business through two segments. The Biologics segment mainly engages in the provision of biologics discovery, development and manufacturing. The WuXi XDC (XDC) segment mainly engages in the provision of contract research, development and manufacturing organization (CRDMO) services for antibody-drug conjugate (ADCs) and various bioconjugates. The firm mainly conducts its business in the domestic and overseas markets.

功能特性

交易策略

资源

市场

Utilizing our sophisticated predictive model, we anticipate notable price fluctuations for 2269.HK in the upcoming periods. Looking toward the future, our 2027 projection indicates an average price target of $40.88. The lowest target is $30.3 and the highest is $54.6. Empower your investment choices with our cutting-edge, data-driven analysis!

2269.HK 股价预测摘要

2269.HK的顶级分析师评级

基于 33 位分析师对 2269.HK 的股票评级，更新于 Jan 01, 2026

Buy

Strong buy

Buy

Hold

Sell

Strong sell

Leveraging in-depth analyst evaluations, we have synthesized key insights from expert assessments to present a positive outlook for 2269.HK. Analysts highlight solid fundamentals and favorable market sentiment, suggesting upside potential in the near term. Based on this thorough expert analysis, we maintain an optimistic view of this stock. Our conclusion: 2269.HK is a Buy candidate.

2269.HK stock price ended at $37.1 on 星期二, after dropping 2.01%

On the latest trading day Jan 20, 2026, the stock price of 2269.HK fell by 2.01%, dropping from $37.52 to $37.10. During the session, the stock saw a volatility of 3.54%, with prices oscillating between a daily low of $36.68 and a high of $37.98. On the latest trading day, the trading volume for 2269.HK decreased by 12.9M shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 28.3M shares were traded, with a market value of approximately $153.1B.

2269.HK 技术面信号

技术面信号摘要

购买信号 5

中性信号 2

卖出信号 0

Strong Sell

Sell

Neutral

Buy

Strong Buy

2269.HK目前显示5个买入信号和0个卖出信号。该股票自12:00 AM以来一直处于下降趋势状态，在此期间价格总变动为-7.3%。总体而言，技术指标显示中期前景为Strong Buy。

2269.HK 的看涨/看跌信号

我们的算法通过分析移动平均线、RSI、MACD 和成交量等关键指标，为 2269.HK 生成看涨和看跌信号。这些见解可助您做出明智的投资决策。

后续问题

技术分析指标如何适用于 2269.HK？



2269.HK 的斐波那契回调水平是多少？



WuXi Biologics (Cayman) Inc. 的 RSI 是多少？



WuXi Biologics (Cayman) Inc. 接下来 12 个月的价格是多少？



WuXi Biologics (Cayman) Inc. 预计会涨到多高？



WuXi Biologics (Cayman) Inc.（2269.HK）价格

2269.HK 股价走势图